期刊文献+

以个体化行为干预为核心的移动医疗APP院外管理对2型糖尿病患者血糖及用药依从性的影响 被引量:24

Effect of mobile medical APP based on individualized behavior intervention on blood glucose and medication compliance in patients with type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨以个体化行为干预为核心,应用移动医疗APP进行院外管理,对T2DM患者BG控制及用药依从性的影响。方法选取2017年4月至2018年3月于南京中医药大学附属中西医结合医院内分泌科住院治疗的T2DM患者300例,随机分为个体化行为干预联合APP组(APP,n=150)与个体化行为干预组(Con,n=150)。结果APP组6、12个月时的HbA1c低于基线水平[(7.57±1.47)%、(7.41±1.29)%vs(8.49±2.01)%,P<0.01]。Con组6、12个月时的HbA1c低于基线水平[(8.01±1.62)%、(7.79±1.44)%vs(8.66±1.74)%,P<0.01]。APP组用药依从性量表条目1、8得分变化优于Con组(P<0.05)。Con、APP组干预12个月后用药依从性总分均高于基线水平(P<0.05)。结论以个体化行为干预为核心,联合使用移动医疗APP的管理模式能有效改善患者HbA1c,提醒患者按时用药,减少忘记服药次数,提高用药依从性。 Objective To explore the effect on blood glucose control and medication compliance of patients with type 2 diabetes mellitus(T2DM)by using mobile medical APP with individualized behavior in⁃tervention as the core.Methods 300 T2DM patients hospitalized in Endocrinology Department in Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine were enrolled in the study.They were randomly divided into two groups:individual behavior intervention combined with APP intervention group(APP,n=150)and individual behavior intervention control group(Con,n=150).Results In APP group,the HbA1c at 6 and 12 months was significantly decreased[(7.57±1.47)%,(7.41±1.29)%vs(8.49±2.01)%,P<0.01].In Con group,HbA1c was significantly decreased at 6 and 12 months[(8.01±1.62)%,(7.79±1.44)%vs(8.66±1.74)%,P<0.01].The changes in the score of items 1 and 8 of MMAS⁃8 was significantly better in APP group than in Con group(P<0.05).The compliance with medication was significantly improved after 12 months(P<0.05)in both groups(P<0.05).Conclusion With individual behavior intervention as the core,the management mode combined use of mobile health APP can effectively and continuously improve HbA1c,reduce the difficulty of remembering to use drugs and the frequency of forgetting to take drugs,and improve patients’compliance with medication.
作者 袁晓丹 郑仁东 高珍秀 严娟 姚平 楼青青 YUAN Xiaodan;ZHENG Rendong;GAO Zhenxiu(Department of Health Education,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210028,China)
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2020年第11期827-832,共6页 Chinese Journal of Diabetes
基金 江苏省卫生计生科研课题(N2017003) 江苏高校护理学优势学科建设工程资助项目(2019YSHL124)。
关键词 移动医疗APP 行为干预 糖尿病 2型 用药依从性 Mobile health APP Behavior intervention Diabetes mellitus,type 2 Medication compliance
  • 相关文献

参考文献6

二级参考文献25

  • 1张楚莹,谢少花,李悦侬,李作彬.汕头市澄海区2型糖尿病患者服药依从性调查[J].中国临床康复,2005,9(7):14-15. 被引量:6
  • 2Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient selting. J Clin Hypertens(Greenwich), 2008,10 : 348-,354. 被引量:1
  • 3AI-Qazaz HKh, Hassali MA, Shafie AA, et al. The eight item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Prac, 2010,90:216 221. 被引量:1
  • 4Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psycho- metric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother, 2009,43 : 950-957. 被引量:1
  • 5Bowling A. Research methods in health: investigating health and health services. Buckingham: Open University Press, 2002. 被引量:1
  • 6Robinson JP,Shaver PR,Wrightsman LS. Measures of person ality and social psychological attitudes. San Diego, CA: Aca- demic Press, 1991. 被引量:1
  • 7Rosner B. Fundamentals of biostatistics, 5th ed. Paci{ic Grove, CA: Duxbury Thomson Learning, 2000. 被引量:1
  • 8Cohen JW. Statistical power analysis for the behavioural sciences, 2nd ed. Hillsdale, NJ : Lawrence Erlbaum Assodates, 1988. 被引量:1
  • 9US Food and Drug Administration. Mobile medical applications:guidance fi~r industry and Food and I')rug Administration sta ff[EB/(3k I.[2013-OC)-251.http://www. fda.gov/do\vnloads/MedicalDevices/ l')evicel~ egulatio n a n d(;uid an c e / GuidanceD(~cuments/U('.M263366.pdt. 被引量:1
  • 10http:/ /www.businesswire.com/news/ home/20l 306130O5377/en/WelIDoc- Launches- BlueStar- FDA-Cleared-Mobile- Prescription -Therapy. 被引量:1

共引文献255

同被引文献395

引证文献24

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部